1. Home
  2. PTCT vs PIPR Comparison

PTCT vs PIPR Comparison

Compare PTCT & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.14

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$78.19

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
PIPR
Founded
1998
1895
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.8B
IPO Year
2006
2003

Fundamental Metrics

Financial Performance
Metric
PTCT
PIPR
Price
$69.14
$78.19
Analyst Decision
Buy
Buy
Analyst Count
17
3
Target Price
$80.65
$91.38
AVG Volume (30 Days)
915.0K
358.4K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
2.50%
EPS Growth
264.48
54.49
EPS
7.78
15.82
Revenue
$264,734,000.00
$1,904,217,000.00
Revenue This Year
N/A
$13.14
Revenue Next Year
$19.30
$13.08
P/E Ratio
$8.71
$4.92
Revenue Growth
36.19
24.33
52 Week Low
$35.95
$72.48
52 Week High
$87.50
$380.26

Technical Indicators

Market Signals
Indicator
PTCT
PIPR
Relative Strength Index (RSI) 55.26 13.36
Support Level $64.00 $72.48
Resistance Level $69.23 $347.70
Average True Range (ATR) 2.24 4.87
MACD 0.57 -11.58
Stochastic Oscillator 81.53 2.33

Price Performance

Historical Comparison
PTCT
PIPR

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

Share on Social Networks: